|
Swairjo, M A; Towler, E M; Debouck, C et al. (1998) Structural role of the 30's loop in determining the ligand specificity of the human immunodeficiency virus protease. Biochemistry 37:10928-36
|
|
Towler, E M; Gulnik, S V; Bhat, T N et al. (1998) Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease? Biochemistry 37:17137-44
|
|
Stebbins, J; Towler, E M; Tennant, M G et al. (1997) The 80's loop (residues 78 to 85) is important for the differential activity of retroviral proteases. J Mol Biol 267:467-75
|
|
Stebbins, J; Debouck, C (1997) A microtiter colorimetric assay for the HIV-1 protease. Anal Biochem 248:246-50
|
|
Towler, E M; Thompson, S K; Tomaszek, T et al. (1997) Identification of a loop outside the active site cavity of the human immunodeficiency virus proteases which confers inhibitor specificity. Biochemistry 36:5128-33
|
|
Towler, E M; Stebbins, J W; Debouck, C (1996) A single vector cloning, mutagenesis and expression system. Gene 183:259-63
|
|
Hoog, S S; Towler, E M; Zhao, B et al. (1996) Human immunodeficiency virus protease ligand specificity conferred by residues outside of the active site cavity. Biochemistry 35:10279-86
|
|
Stebbins, J; Deckman, I C; Richardson, S B et al. (1996) A heterologous substrate assay for the HIV-1 protease engineered in Escherichia coli. Anal Biochem 242:90-4
|
|
Hoog, S S; Zhao, B; Winborne, E et al. (1995) A check on rational drug design: crystal structure of a complex of human immunodeficiency virus type 1 protease with a novel gamma-turn mimetic inhibitor. J Med Chem 38:3246-52
|
